December 12, 2006 — Health Canada has approved a pen-like device for administering adalimumab in the treatment of moderate to severe rheumatoid arthritis and psoriatic arthritis; the European ...
AbbVie GK, Eisai Co. and EA Pharma Co. have debuted the HUMIRA Pen, an auto-injector pen meant to help simplify self-injection. The product, which has a rounded pen-type body designed to help patients ...
Fresenius Kabi has obtained the Food and Drug Administration’s permission for its citrate-free adalimumab biosimilar Idacio for use in the treatment of chronic autoimmune diseases for all eligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results